Infiltration by myeloperoxidase-positive neutrophils is an independent prognostic factor in breast cancer

Jasmin Zeindler,Fiorenzo Angehrn,Raoul Droeser,Silvio Däster,Salvatore Piscuoglio,Charlotte K. Y. Ng,Ergin Kilic,Robert Mechera,Samuel Meili,Andrej Isaak,Walter P. Weber,Simone Muenst,Savas Deniz Soysal

DOI: https://doi.org/10.1007/s10549-019-05336-3

2019-07-02

Breast Cancer Research and Treatment

Abstract:<h3 class="Heading">Purpose</h3><p class="Para">Myeloperoxidase (MPO) is an enzyme secreted by neutrophil granulocytes as a result of phagocytosis during inflammation. In colorectal cancer, tumour infiltration by MPO expressing cells has been shown to be independently associated with a favourable prognosis. In this study, we explored the role of MPO-positive cell infiltration and its prognostic significance in invasive breast cancer.</p><h3 class="Heading">Methods</h3><p class="Para">We performed immunohistochemical staining for MPO on multiple tissue microarrays comprising a total of 928 human breast cancer samples with detailed clinical-pathological annotation and outcome data.</p><h3 class="Heading">Results</h3><p class="Para">MPO-positive cell infiltration (≥ 5 cells/tissue punch) was found in 150 (16%) of the 928 evaluable breast cancer cases. In univariate survival analyses, infiltration by MPO-positive cells was associated with a significantly better overall survival (<em class="EmphasisTypeItalic">p</em> &lt; 0.001). In subset univariate analyses, the infiltration by MPO-positive cells was associated with significantly better overall survival in the Luminal B/HER2-negative subtype (<em class="EmphasisTypeItalic">p</em> = 0.005), the HER2 enriched subtype (<em class="EmphasisTypeItalic">p</em> = 0.011), and the Triple Negative subtype (<em class="EmphasisTypeItalic">p</em> &lt; 0.001). In multivariate analysis, MPO expression proved to be an independent prognostic factor for improved overall survival (<em class="EmphasisTypeItalic">p</em> &lt; 0.001).</p><h3 class="Heading">Conclusions</h3><p class="Para">This is the first study to show that infiltration of MPO-positive cells is an independent prognostic biomarker for improved overall survival in human breast cancer.</p>

oncology